Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Operations

v3.7.0.1
Condensed Consolidated Statements Of Operations - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Condensed Consolidated Statements Of Operations [Abstract]        
Net revenues $ 4,314,068 $ 5,560,776 $ 9,963,186 $ 18,564,236
Cost of sales 2,019,154 2,327,583 4,738,333 7,083,311
Gross profit 2,294,914 3,233,193 5,224,853 11,480,925
Operating expenses:        
Selling, general and administrative 3,134,239 2,361,951 8,909,939 8,073,288
Research and development 426,811 22,723 2,034,973 96,138
Total operating expenses 3,561,050 2,384,674 10,944,912 8,169,426
Operating (loss) income (1,266,136) 848,519 (5,720,059) 3,311,499
Non-operating expenses:        
Interest and other expense, net (13,323) (7,399) (35,630) (54,551)
Foreign currency transaction loss (20,143) (39,651) (40,838) (128,442)
Total non-operating expenses (33,466) (47,050) (76,468) (182,993)
(Loss) Income before income taxes (1,299,602) 801,469 (5,796,527) 3,128,506
Income tax (benefit) expense (509,713) 231,211 (1,863,815) 1,032,840
Net (loss) income $ (789,889) $ 570,258 $ (3,932,712) $ 2,095,666
Net (loss) income per basic common share outstanding $ (0.03) $ 0.02 $ (0.13) $ 0.07
Basic weighted average common shares outstanding 30,991,247 28,655,970 30,983,271 28,647,275
Net (loss) income per diluted common share outstanding $ (0.03) $ 0.02 $ (0.13) $ 0.07
Diluted weighted average common shares outstanding 30,991,247 29,054,147 30,983,271 29,058,576